No Dye: Cancer Patients’ Gray Hair Darkened on Immune Drugs – U.S. News & World Report
U.S. News & World Report |
No Dye: Cancer Patients’ Gray Hair Darkened on Immune Drugs
U.S. News & World Report This undated combination of photos provided by the Journal of the American Medical Association in July 2017 shows a cancer patient with gray hair that unexpectedly turned dark while taking new immunotherapy drugs. Fourteen such cases were among 52 … Cancer patients’ grey hair unexpectedly darkens in drug studyThe Guardian No dye: Cancer patients’ gray hair darkened on immune drugs – The …The Edwardsville Intelligencer |
|
TDU launches seminar series to support outlining international and national policy on synthetic biology
Daily News & Analysis Synthetic Biology is bringing together disparate disciplines like engineering, computer science, biotechnology and molecular biology to revolutionise the way we live. But how can India be a part of this revolution? The TransDisciplinary University (TDU … |
|
Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy
Science Daily “The challenge so far has been finding the most effective immunotherapy targets and prioritizing those that work best when combined with PD-1 inhibitors,” Haining says. “So, we set out to develop a better system for identifying new drug targets that … |
|
QoL better with bladder Ca immunotherapy vs. chemo
ModernMedicine Chicago—Patients treated with pembrolizumab (Keytruda) as second-line therapy for advanced urothelial carcinoma (UC) following platinum-based chemotherapy maintain better health-related quality of life (HRQoL) than their counterparts receiving … |
|
COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
Oncology Nurse Advisor Many tumor cells are resistant to immunotherapy due to IDO1 expression. In adaptive resistance, the tumor cells starts to produce IDO1 — which is associated with inflammation and T-cell infiltration — upon T-cell attack. In intrinsic resistance, the … COX-2 inhibitors may reverse IDO1-mediated immunosuppression in some cancersMedical Xpress |
|
TransDisciplinary University Brings Together the Best Minds to Deliberate over the Promise and Problems of Synthetic …
Business Wire India (press release) Speaking on the occasion, Dr. Balakrishna Pisupati, Vice-chancellor, TDU, said, “In less than a decade, Synthetic Biology has managed to garner the attention of top technologists, researchers and policy makers worldwide. Countries like Australia and … |
Genetic Engineering & Biotechnology News |
CRISPR Structure Data Reveal How Cas Enzymes Choose Target
Genetic Engineering & Biotechnology News New data from Jennifer Doudna, Ph.D., co-pioneer of the CRISPR/Cas9 genome-editing technology, and her research group at the University of California, Berkeley show that for bacterial adaptive immunity to achieve site-selective expansion, the CRISPR … This Week in ScienceGenomeWeb |
|
Alligator, Aptevo Partner on Bispecific Cancer Immunotherapy …
Genetic Engineering & Biotechnology News (blog) Swedish firm Alligator Bioscience and Seattle-based Aptevo Therapeutics have agreed to co-develop ALG.APV-527, a bispecific antibody for tumor-directed … Alligator Bioscience AB: Aptevo Therapeutics and Alligator …GlobeNewswire (press release) |